Discover
FBLG
FibroBiologics, Inc. Common Stock
0.77
1 x 0.70
36 x 0.84
bid
ask
-
0.01
1.01%
1 @ 04:00 PM
0.81 +0.03 (4.13%)
| Ytd | -82.82% | |
| 1y | -94.20% |
0.76
day range
0.80
0.73
52 week range
14.40
| Open | 0.77 | Prev Close | 0.78 | Low | 0.76 | High | 0.80 | Mkt Cap | 1.62M |
| Vol | 112.71K | Avg Vol | 214.44K | EPS | -2.56 | P/E | -0.30 | Forward P/E | -5.83 |
| Beta | 1.14 | Short Ratio | 13.56 | Inst. Own | 15.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.94 | 200-d Avg | 4.44 | 1yr Est | 12.75 |
| Income Statement | |||
| Operating Expenses | 5.07M | ||
| Research and Development Expense | 2.95M | ||
| Selling, General and Administrative Expense | 2.12M | ||
| Operating Income | -5.07M | ||
| Interest Expense | 4.00K | ||
| Net Income | -5.00M | ||
| Net Income Common Stock | -5.00M | ||
| Net Income Common Stock (USD) | -5.00M | ||
| Consolidated Income | -5.00M | ||
| Earnings per Basic Share | -1.33 | ||
| Earnings per Basic Share (USD) | -1.33 | ||
| Earnings per Diluted Share | -1.33 | ||
| Earning Before Interest & Taxes (EBIT) | -5.00M | ||
| Earning Before Interest & Taxes (USD) | -5.00M | ||
| Weighted Average Shares | 3.77M | ||
| Weighted Average Shares Diluted | 3.77M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.48M | ||
| Cash and Equivalents (USD) | 1.48M | ||
| Current Assets | 2.91M | ||
| Property, Plant & Equipment Net | 2.99M | ||
| Total Assets | 5.94M | ||
| Debt Current | 969.00K | ||
| Total Debt | 2.48M | ||
| Current Liabilities | 1.83M | ||
| Debt Non-Current | 1.51M | ||
| Total Liabilities | 3.34M | ||
| Accumulated Retained Earnings (Deficit) | -59.16M | ||
| Shareholders Equity | 2.60M | ||
| Shareholders Equity (USD) | 2.60M | ||
| Assets Non-Current | 3.03M | ||
| Total Debt (USD) | 2.48M | ||
| Liabilities Non-Current | 1.51M | ||
| Trade and Non-Trade Payables | 850.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 237.00K | ||
| Net Cash Flow from Financing | 952.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.41M | ||
| Issuance (Purchase) of Equity Shares | 706.00K | ||
| Issuance (Repayment) of Debt Securities | 246.00K | ||
| Net Cash Flow from Operations | -4.36M | ||
| Share Based Compensation | 694.00K | ||